MENU
+Compare
APNHF
Stock ticker: OTC
AS OF
Oct 16 closing price
Price
$6.23
Change
-$1.02 (-14.07%)
Capitalization
2.6B

APNHF Aspen Pharmacare Holdings plc Forecast, Technical & Fundamental Analysis

Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form... Show more

APNHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for APNHF with price predictions
Oct 17, 2025

APNHF sees MACD Histogram just turned negative

APNHF saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 16, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 13 instances where the indicator turned negative. In of the 13 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 16, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on APNHF as a result. In of 12 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

APNHF moved below its 50-day moving average on October 16, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for APNHF crossed bearishly below the 50-day moving average on October 16, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 6 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.566) is normal, around the industry mean (17.766). P/E Ratio (12.676) is within average values for comparable stocks, (72.923). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.078). Dividend Yield (0.020) settles around the average of (0.030) among similar stocks. P/S Ratio (1.108) is also within normal values, averaging (46.182).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. APNHF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. APNHF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
APNHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
Douglas Saunders Drive
Phone
+27 315808600
Employees
9161
Web
https://www.aspenpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TLVIX32.960.18
+0.55%
Thrivent Large Cap Value S
JVMAX27.840.12
+0.43%
JHancock Disciplined Value Mid Cap A
ATWAX25.980.04
+0.15%
AB Tax-Managed Wealth Apprec Strat A
ICTEX18.170.01
+0.06%
ICON Health and Information Tech Instl
WEGRX12.57-0.07
-0.55%
Allspring Emerging Growth R6

APNHF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, APNHF has been loosely correlated with GEDSF. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if APNHF jumps, then GEDSF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APNHF
1D Price
Change %
APNHF100%
N/A
GEDSF - APNHF
51%
Loosely correlated
N/A
MSTH - APNHF
39%
Loosely correlated
N/A
ORXOY - APNHF
29%
Poorly correlated
N/A
QNTM - APNHF
4%
Poorly correlated
-6.04%
ORGO - APNHF
1%
Poorly correlated
-0.49%
More

Groups containing APNHF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APNHF
1D Price
Change %
APNHF100%
N/A
Pharmaceuticals: Generic
industry (218 stocks)
-8%
Poorly correlated
-0.26%